Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

660 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Duration of anticoagulant treatment after venous thromboembolism.
Becattini C, Agnelli G. Becattini C, et al. Among authors: agnelli g. Pathophysiol Haemost Thromb. 2003 Sep-2004 Dec;33(5-6):354-7. doi: 10.1159/000083828. Pathophysiol Haemost Thromb. 2003. PMID: 15692243 Free article. Review. No abstract available.
Initial treatment of venous thromboembolism.
Becattini C, Agnelli G, Emmerich J, Bura A, Weitz JI. Becattini C, et al. Among authors: agnelli g. Thromb Haemost. 2006 Sep;96(3):242-50. doi: 10.1160/TH06-05-0260. Thromb Haemost. 2006. PMID: 16953263 Review.
New anticoagulants.
Agnelli G, Becattini C. Agnelli G, et al. Semin Thromb Hemost. 2006 Nov;32(8):793-802. doi: 10.1055/s-2006-955462. Semin Thromb Hemost. 2006. PMID: 17171592 Review.
Anticoagulants in heart disease: current status and perspectives.
De Caterina R, Husted S, Wallentin L, Agnelli G, Bachmann F, Baigent C, Jespersen J, Kristensen SD, Montalescot G, Siegbahn A, Verheugt FW, Weitz J. De Caterina R, et al. Among authors: agnelli g. Eur Heart J. 2007 Apr;28(7):880-913. doi: 10.1093/eurheartj/ehl492. Epub 2007 Apr 10. Eur Heart J. 2007. PMID: 17426080 Free article. No abstract available.
Treatment of proximal deep-vein thrombosis with the oral direct factor Xa inhibitor rivaroxaban (BAY 59-7939): the ODIXa-DVT (Oral Direct Factor Xa Inhibitor BAY 59-7939 in Patients With Acute Symptomatic Deep-Vein Thrombosis) study.
Agnelli G, Gallus A, Goldhaber SZ, Haas S, Huisman MV, Hull RD, Kakkar AK, Misselwitz F, Schellong S; ODIXa-DVT Study Investigators. Agnelli G, et al. Circulation. 2007 Jul 10;116(2):180-7. doi: 10.1161/CIRCULATIONAHA.106.668020. Epub 2007 Jun 18. Circulation. 2007. PMID: 17576867 Clinical Trial.
660 results